Purpose: To investigate the potential predictive factors of the visual change achieved with accelerated epi-on and epi-off corneal collagen crosslinking (CXL) in keratoconus.
Methods: This retrospective comparative study analyzed 67 eyes treated with an accelerated epithelium-on (epi-on group) and epithelium-off (epi-off group) CXL. The clinical outcomes were evaluated and compared during a 1-year follow-up. Likewise, the relationship of the change achieved with both CXL techniques in the corrected distance visual acuity (CDVA) with different preoperative data was investigated.
Results: The mean CDVA change at 3 months postoperatively was -0.04 ± 0.19 and -0.07 ± 0.25 in the epi-on and epi-off groups, respectively ( = 0.809). In the epi-on group, this change was significantly correlated with the preoperative apical ( = -0.375, = 0.045) and central corneal thickness ( = -0.402, = 0.031). In the epi-off group, the CDVA change was significantly correlated with not only the preoperative apical ( = 0.402, = 0.028) and central corneal thickness ( = 0.367, = 0.046) but also with some topometric and aberrometric indices ( ≤ -0.374, ≤ 0.042). Furthermore, the change in CDVA in the epi-on group could be predicted from age, preoperative refractive astigmatism J component, anterior corneal asphericity, and posterior corneal high order aberration root mean square ( = 0.002, = 0.503). In the epi-off group, the CDVA change could be predicted from the preoperative minimum corneal thickness and magnitude of the vertical anterior corneal primary coma component ( = 0.001, = 0.446).
Conclusions: Clearly, different predictive factors of the visual change induced with the accelerated epi-on and epi-off CXL techniques are present, suggesting a different mechanism of action for stiffening the cornea and inducing changes in this structure.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670975 | PMC |
http://dx.doi.org/10.1155/2021/9680253 | DOI Listing |
Curr Eye Res
November 2024
Department of Ophthalmology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Purpose: Corneal collagen cross-linking (CXL) can halt corneal ectasia. Leaving corneal epithelium intact during treatment may reduce the incidence of complications. However, it is under debate whether this reduces efficacy and if oxygen supplementation may be necessary to optimize the cross-linking effect.
View Article and Find Full Text PDFInt J Pharm
May 2024
Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India. Electronic address:
Corneal collagen crosslinking (CXL) is an effective method to halt the disease progression of keratoconus, a progressive corneal dystrophy leading to cone shaped cornea. Despite the efficacy of standard protocol, the concerning step of this procedure is epithelial debridement performed to facilitate the entry of riboflavin drug. Riboflavin, a key molecule in CXL protocol, is a sparsely permeable hydrophilic drug in corneal tissues.
View Article and Find Full Text PDFGraefes Arch Clin Exp Ophthalmol
August 2024
Studio Italiano di Oftalmologia, Via Livenza 3, 00198, Rome, Italy.
Purpose: To assess the feasibility of theranostics to determine the riboflavin concentration in the cornea using clinically available ophthalmic formulations during epithelium-off (epi-off) and transepithelial (epi-on) corneal cross-linking procedures.
Methods: Thirty-two eye bank human donor corneas were equally randomized in eight groups; groups 1 to 3 and groups 4 to 8 underwent epi-off and epi-on delivery of riboflavin respectively. Riboflavin ophthalmic solutions were applied onto the cornea according to the manufacturers' instructions.
J Cataract Refract Surg
July 2024
From the Department of Clinical Sciences/Ophthalmology, Umeå University, Umeå, Sweden .
Purpose: To compare clinical outcomes of customized transepithelial (epi-on) corneal crosslinking (CXL) in high oxygen and customized CXL with epithelial removal (epi-off) in room air for keratoconus (KC).
Setting: Umeå University Hospital, Umeå, Sweden.
Design: Prospective, randomized, single-masked, intraindividually comparing study.
Cureus
January 2024
Internal Medicine, University Hospitals of Leicester NHS Trust, Leicester, GBR.
Keratoconus (KC) incidence is on the increase. The advent of corneal-collagen cross-linking (CXL) has revolutionized the management of KC. This systematic review looks at the efficacy and complications of two novel treatments within CXL: Epithelial-On (Epi-On) and CXL-plus procedures.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!